# Substance Use Treatment Services in New York (2021–2023): A State Profile Analysis Based on National Survey of Substance Abuse and Mental Health Services (N-SUMHSS) Data

## TL;DR

This study examines trends in substance use treatment services in New York from 2021 to 2023, focusing on facility types and medication-assisted treatment usage.

## Contribution

The study provides a detailed analysis of treatment trends in New York using N-SUMHSS data, highlighting changes in MAT utilization and facility types.

## Key findings

- Private non-profit organizations comprised 69.7% of treatment facilities in 2022-2023.
- MAT utilization declined in opioid treatment programs and non-OTP facilities, with methadone remaining prevalent.
- Outpatient services increased to 72.1%, while residential and hospital inpatient facilities saw slight declines.

## Abstract

Background: Substance use disorders (SUDs) are a significant public health issue in the U.S., with New York State facing rising treatment demands. The National Survey of Substance Abuse and Mental Health Services (N-SUMHSS) offers valuable data on treatment trends across the state.

Objective: This study analyzes trends in substance use treatment services in New York from 2021 to 2023 using N-SUMHSS data, focusing on facility capacity, medication-assisted treatment (MAT) utilization, and treatment effectiveness.

Methods: Secondary data from the N-SUMHSS (2021-2023) were analyzed, examining facility types, client numbers, and MAT use (methadone, buprenorphine, naltrexone). Descriptive statistics and trend analysis were conducted to assess changes in treatment services.

Results: From 2021 to 2023, the number of facilities remained stable, with slight fluctuations. Private non-profit organizations dominated, comprising 69.7% of facilities in 2022-2023. MAT utilization declined in both opioid treatment programs (OTPs) and non-OTP facilities, with methadone usage remaining prevalent. Clients receiving MAT at OTP facilities decreased from 39,534 (9.3%) in 2021 to 34,186 (7.8%) in 2023, while naltrexone use rose. Outpatient services increased to 547 (72.1%), while residential and hospital inpatient facilities saw slight declines.

Conclusion: MAT utilization has improved, but challenges persist in addressing the growing demand for residential and detox services. Expanding outpatient and inpatient services, along with greater access to MAT, is crucial to improving treatment in New York.